Pauling
Boston
About Pauling
Pauling AI offers an autonomous drug-discovery AI platform that turns research ideas into validated molecular candidates.
Company Facts
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Dec 2024)
- Website: pauling.ai
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/pauling-8424498 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.